12:00 AM
Apr 11, 2011
 |  BC Week In Review  |  Company News  |  Other News

Actelion cardiovascular, metabolic news

Actelion nominated two new directors for election to the biotech's board at its annual meeting on May 5. The nominees are Jean-Pierre Garnier, former CEO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.); and Robert Bertolini, former...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >